다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

CUE

Cue Biopharma (CUE)

Cue Biopharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CUE

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/10	05:05	GlobeNewswire Inc.	Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights	NASDAQ:CUE	Cue Biopharma Inc
2024/05/10	05:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CUE	Cue Biopharma Inc
2024/05/10	05:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CUE	Cue Biopharma Inc
2024/05/08	21:00	GlobeNewswire Inc.	Cue Biopharma to Present at the 20th Annual PEGS Boston Summit	NASDAQ:CUE	Cue Biopharma Inc
2024/05/07	21:00	GlobeNewswire Inc.	Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences Conference	NASDAQ:CUE	Cue Biopharma Inc
2024/04/24	23:01	GlobeNewswire Inc.	Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:CUE	Cue Biopharma Inc
2024/04/09	05:05	GlobeNewswire Inc.	Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights	NASDAQ:CUE	Cue Biopharma Inc
2024/04/02	21:00	GlobeNewswire Inc.	Cue Biopharma to Host Business Update Call and Webcast	NASDAQ:CUE	Cue Biopharma Inc
2024/03/09	06:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CUE	Cue Biopharma Inc
2024/03/09	06:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CUE	Cue Biopharma Inc
2024/03/09	06:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CUE	Cue Biopharma Inc
2024/03/09	06:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CUE	Cue Biopharma Inc
2024/03/01	00:00	GlobeNewswire Inc.	Cue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium	NASDAQ:CUE	Cue Biopharma Inc
2024/02/23	06:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CUE	Cue Biopharma Inc
2024/02/06	22:00	GlobeNewswire Inc.	Cue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	NASDAQ:CUE	Cue Biopharma Inc
2024/01/05	06:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CUE	Cue Biopharma Inc
2024/01/05	06:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CUE	Cue Biopharma Inc
2024/01/05	06:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CUE	Cue Biopharma Inc
2023/11/22	22:00	GlobeNewswire Inc.	Cue Biopharma to Present at the JMP Securities Hematology and Oncology Summit	NASDAQ:CUE	Cue Biopharma Inc
2023/11/10	06:05	GlobeNewswire Inc.	Cue Biopharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights	NASDAQ:CUE	Cue Biopharma Inc
2023/11/07	22:00	GlobeNewswire Inc.	Cue Biopharma to Present at Three Upcoming Investor Healthcare Conferences in November	NASDAQ:CUE	Cue Biopharma Inc
2023/11/04	05:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CUE	Cue Biopharma Inc
2023/11/04	01:00	GlobeNewswire Inc.	Cue Biopharma Presents New Positive Data from Phase 1 Trials of CUE-101 in Head and Neck Cancer and CUE-102 in Wilms’ Tumor 1 Positive Cancers at SITC 2023	NASDAQ:CUE	Cue Biopharma Inc
2023/11/02	21:00	GlobeNewswire Inc.	Cue Biopharma to Host Business Update Call and Webcast	NASDAQ:CUE	Cue Biopharma Inc
2023/09/27	22:05	GlobeNewswire Inc.	Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting	NASDAQ:CUE	Cue Biopharma Inc
2023/09/26	21:00	GlobeNewswire Inc.	Cue Biopharma Announces Completion of Patient Enrollment in Phase 1b Study of CUE-101 in Combination with KEYTRUDA®	NASDAQ:CUE	Cue Biopharma Inc
2023/09/15	05:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CUE	Cue Biopharma Inc
2023/08/30	05:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CUE	Cue Biopharma Inc
2023/08/10	05:10	GlobeNewswire Inc.	Cue Biopharma Reports Second Quarter 2023 Financial Results and Recent Business Highlights	NASDAQ:CUE	Cue Biopharma Inc
2023/08/09	05:04	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CUE	Cue Biopharma Inc

검색 관련기사 보기:NASDAQ:CUE

1 2 3 4 5 6 7 8 9 10 다음 >>

Vontobel Financial Produ...

Kapital DAO Token

Vontobel Financial Produ...

Societe Generale Effekten

American Century

Xtrackers India Governme...

USIMQ12 Ex:11,72

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관